LMNX

Q: What is the price of Luminex (LMNX) today?

The current price of Luminex (LMNX) is $ 19.60, representing a 0% gain over the past year. The stock began the year trading around $ 29.72 and is currently priced at $ 19.60. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Luminex (LMNX) pay dividends?

Luminex (LMNX) did not pay dividends over the past year.

Q: Is Luminex (LMNX) a good investment?

Luminex (LMNX) is currently trading at $ 19.60 with a P/E ratio of 45.18%. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Luminex Corporation

Price

$ 19.60

return (12m)

0.00%

p/e

45.18

p/bv

2.14

DIVIDEND YIELD

0.00%

LMNX price

LMNX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment LMNX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-3.13%

3 months

-59.22%

1 year

0.00%

2 years

0.00%

5 years

-46.61%

10 years

0.69%

Fundamentals LMNX

review the fundamentals of Luminex shares

P/E

45.18

Sector: -4.11 Industry: -4.11

P/S (PSR)

2.39

Sector: -3.78 Industry: -3.78

P/BV

2.14

Sector: 1.95 Industry: 1.95

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

2.83%

Sector: -61.23% Industry: -61.23%

ROE

4.74%

Sector: -60.44% Industry: -60.44%

ROIC

Sector: -1,165.26% Industry: -1,165.26%

NET MARGIN

5.29%

Sector: -39.16% Industry: -39.16%

GROSS MARGIN

60.31%

Sector: 37.92% Industry: 37.92%

OPERATING MARGIN

12.40%

Sector: -39.32% Industry: -39.32%

EV/EBITDA

19.27

Sector: -4.00 Industry: -4.00

EV/EBIT

44.74

Sector: -4.22 Industry: -4.22

PRICE-TO-ASSETS

1.28

Sector: 1.44 Industry: 1.44

BVPS

10.46

Sector: 1.88 Industry: 1.88

EPS

0.50

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.60

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.40

Sector: 0.38 Industry: 0.38

CAGR REVENUE 5 YEARS

31.65%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

21.05%

Sector: - Industry: -

FAIR VALUE OF Luminex ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 19.60

Fair Value

$ 0.00

Upside/Downside Return potential.

-44.65%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals LMNX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	20.93	7.08	33.81%	2.23%	$ 560.91 B	28.46%
PFE	20.17	1.68	8.35%	6.24%	$ 156.71 B	12.42%
ABBV	87.13	0.00	0.00%	3.19%	$ 368.21 B	6.91%
NVO	11.49	5.92	51.50%	4.60%	$ 179.95 B	33.05%
MRK	16.19	0.00	0.00%	2.79%	$ 295.53 B	28.08%
AZN	31.07	6.52	20.99%	1.56%	$ 317.64 B	17.41%
GILD	20.09	7.56	37.62%	2.32%	$ 170.95 B	28.90%
BMY	17.19	-3.56	-20.72%	4.18%	$ 121.26 B	14.64%
ZTS	20.05	16.09	80.25%	1.66%	$ 53.60 B	28.23%
REGN	17.16	2.47	14.41%	0.48%	$ 77.31 B	31.41%
HALO	25.80	167.51	649.21%	0.00%	$ 8.18 B	22.69%
AMGN	24.84	22.12	89.06%	2.72%	$ 191.51 B	20.98%
MCK	24.55	-1,076.41	-4,383.84%	0.37%	$ 106.56 B	1.09%
VRTX	28.35	6.00	21.18%	0.00%	$ 112.06 B	32.94%
CAH	30.39	-18.70	-61.56%	0.95%	$ 50.50 B	0.68%
HRMY	10.77	1.96	18.24%	0.00%	$ 1.71 B	18.27%
ADMA	17.83	5.49	30.78%	0.00%	$ 2.62 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

LMNX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/17/2021	07/08/2021	0,10000000
Dividends	03/25/2021	04/15/2021	0,10000000
Dividends	12/23/2020	01/14/2021	0,10000000
Dividends	09/24/2020	10/15/2020	0,09000000
Dividends	06/18/2020	07/09/2020	0,09000000
Dividends	03/19/2020	04/09/2020	0,09000000
Dividends	12/19/2019	01/15/2020	0,09000000
Dividends	09/26/2019	10/17/2019	0,09000000
Dividends	06/20/2019	07/11/2019	0,06000000
Dividends	03/21/2019	04/11/2019	0,06000000
Dividends	12/20/2018	01/10/2019	0,06000000
Dividends	09/21/2018	10/12/2018	0,06000000
Dividends	06/22/2018	07/13/2018	0,06000000
Dividends	03/23/2018	04/13/2018	0,06000000
Dividends	12/22/2017	01/12/2018	0,06000000
Dividends	09/22/2017	10/13/2017	0,06000000
Dividends	06/23/2017	07/14/2017	0,06000000
Dividends	03/24/2017	04/14/2017	0,06000000

ABOUT Luminex

Luminex Corporation

Average Investor10 user rating

4.0 (0 people)

United States

31 years

Founded: 1995

2000

Time since IPO - 26 years

1.325

Employees

Luminex Corporation (United States) is listed on the Nasdaq and has a market capitalization of $1.05 Billion, with shareholders equity totaling $488.05 Millions.

The company employs approximately 1.325 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Luminex Corporation reported $437.66 Millions in revenue, generating net income of $23.14 Millions.

Key financial metrics include a P/E ratio of 45.18, a price-to-book (P/B) ratio of 2.14, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LMNX.

Market cap

$ 1.05 Billion

Net worth

$ 488.05 Millions

$ 488,047,000.00

Assets

$ 819.03 Millions

$ 819,031,000.00

Total Shares Outstanding

46.68 Millions

46,675,000

Average Daily Trading Volume

$ 57.08 Thousand

$ 57,079.54

Sector

Health Care

Industry

Biotechnology

LMNX

LMNX revenue and profits

Financial Results LMNX

DRAG THE FRAME TO SEE MORE DATA

LMNX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 829.23 20,26% (12M)

P/E

24.55

0.37%

ROE

-4,383.84%

P/BV

-1,076.41

CAH - Cardinal Health

$ 200.55 50,87% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.70

JNJ - Johnson & Johnson

$ 226.10 50,43% (12M)

P/E

20.93

2.23%

ROE

33.81%

P/BV

7.08

PFE - Pfizer

$ 26.80 28,38% (12M)

P/E

20.17

6.24%

ROE

8.35%

P/BV

1.68

ABBV - AbbVie

$ 200.50 17,92% (12M)

P/E

87.13

3.19%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 112.89 48,58% (12M)

P/E

16.19

2.79%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 194.81 42,51% (12M)

P/E

31.07

1.56%

ROE

20.99%

P/BV

6.52

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 829.23 20,26% (12 M)

P/L

24.55

0.37%

ROE

-4,383.84%

P/VP

-1,076.41

CAH - Cardinal Health

$ 200.55 50,87% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.70

JNJ - Johnson & Johnson

$ 226.10 50,43% (12 M)

P/L

20.93

2.23%

ROE

33.81%

P/VP

7.08

PFE - Pfizer

$ 26.80 28,38% (12 M)

P/L

20.17

6.24%

ROE

8.35%

P/VP

1.68

ABBV - AbbVie

$ 200.50 17,92% (12 M)

P/L

87.13

3.19%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 112.89 48,58% (12 M)

P/L

16.19

2.79%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 194.81 42,51% (12 M)

P/L

31.07

1.56%

ROE

20.99%

P/VP

6.52

Frequently Asked Questions

What is the price of Luminex (LMNX) today?

The current price of Luminex (LMNX) is $ 19.60, representing a 0% gain over the past year. The stock began the year trading around $ 29.72 and is currently priced at $ 19.60. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Luminex (LMNX) pay dividends?

Luminex (LMNX) did not pay dividends over the past year.

Is Luminex (LMNX) a good investment?

Luminex (LMNX) is currently trading at $ 19.60 with a P/E ratio of 45.18%. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Luminex (LMNX) stock?

You can buy Luminex (LMNX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol LMNX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Luminex (LMNX) yield today?

Over the past month, Luminex (LMNX) has returned -3.13% — 0.00% over the past year, and -46.61% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Luminex (LMNX) today at the current price of $ 19.60 your total investment would be $ 1,959.94.

Based on historical performance, the investment would have grown to approximately:

$ 1,959.94 after 1 year
$ 1,046.41 after 5 years
$ 1,973.46 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LMNX

Luminex Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LMNX

review the fundamentals of Luminex shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Luminex

Luminex Corporation

United States

31 years

2000

1.325

PROFIT X PRICE LMNX

Financial Results LMNX

LMNX cash flow

Asset, Revenue and Profit Growth - LMNX

LMNX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions